Druggability and molecular docking of essential secondary metabolites from Azadirachta indica leaf against angiotensin converting enzyme-2: Covid-19 in focus
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious and virulent coronavirus that arose in late 2019 and poses great risk to public health and safety. The SARS-CoV-2 utilizes peptidase, angiotensin-converting enzyme 2 (ACE2) for entrance and invasion into host cells....
Saved in:
Main Authors: | Paul Chijioke Ozioko, Ukamaka Owohetete, Daniel Danladi Gaiya |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Nigeria
2025-02-01
|
Series: | African Journal of Pharmaceutical Research and Development (AJOPRED) |
Subjects: | |
Online Access: | https://www.ajol.info/index.php/ajopred/article/view/288097 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
by: Evelyn F Okal, et al.
Published: (2025-02-01) -
Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01) -
Optimization of Protein Hydrolysate from Earthworms (<i>Perionyx excavatus</i>) of Angiotensin-I-Converting Enzyme Inhibitory Activity by One Variable at a Time
by: Phong Thanh Bui, et al.
Published: (2025-01-01) -
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
by: Claire Vinel, et al.
Published: (2025-02-01) -
Prediction of angiogenesis suppression by myricetin from Aeginetia indica via inhibiting VEGFR2 signaling pathway using computer-aided analysis
by: Marjanur Rahman Bhuiyan, et al.
Published: (2025-01-01)